reca Bio
The AI engine accelerating and expanding personalized cancer treatment
Areca Bio's immunogenicity prediction engine identifies the right tumor targets with 3× greater accuracy than industry benchmarks and is powering the next generation of personalized cancer therapy.
Our Approach
Dedicated to delivering treatment innovations for patients
We're transforming personalized cancer vaccine design through cutting-edge computational biology and deep immunological expertise.
AI-Powered Design
Our platform leverages machine learning to analyze tumor genomics and design personalized cancer vaccines tailored to each patient's unique biology.
Rapid Development
Advanced computational methods enable faster vaccine design cycles, reducing the time from genomic analysis to candidate identification.
Precision Targeting
We identify optimal tumor neoantigens and design vaccines that maximize immune response while minimizing off-target effects.
Investors & Recognition
Backed by leading investors
PearX Summer 2026
Used in world-leading medical centers
Ready to partner with us?
Whether you're a biopharma company, research institution, or patient exploring options, contact us to learn how Areca's neoantigen prediction platform can accelerate personalized cancer vaccine design and other applications.